论文部分内容阅读
In the past few years,delivering clinically approved drugs with nanoscale vehicles (10-200 nm)for enhanced cancer therapy has attracted extensive attention,as many kinds of nanocarriers are demonstrated to accumulate within solid tumors for their enhanced permeability and retention effect (EPR)1-2.